Home / Resources / Late Clinical resources

後期臨床

最新のリソース

Certara Enhances Integral Data Repository with Powerful REST API Capabilities in Version 25.4.1

Certara Enhances Integral Data Repository with Powerful REST API Capabilities in Version 25.4.1

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power

Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power

注目コンテンツ

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

Upcoming late clinical webinars

ウェビナー

薬事・メディカルライティング向け生成AI

2025年6月25日 – 10am ET/ 2pm GMT

ウェビナー

Combining mechanistic modeling with machine learning to predict clinical scores in inflammatory bowel disease (IBD)

2025年6月26日 – 10am ET/ 4pm CET

ウェビナー

Transform Your PK/PD Workflow with AI and the Cloud

2025年7月10日 – 11am ET

Latest late clinical blogs

All Late clinical - blog

CERTAINTY 2025: The power of Model-Informed Drug Development

医薬品開発におけるPK/PDモデリングのための機械学習

Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters

Shining a spotlight on Clinical Study Software at the 2024 Pinnacle 21 Enterprise User Group Meeting

Don’t Miss Our Inaugural Event for Biosimulation Users

バイオシミュレーションとAIを活用し、製薬企業が直面する研究開発生産性の課題を解決するには

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

2025 Korea CDISC Day

2025年6月24日 – Seoul

展示会・学会

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois

All late clinical resources

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Certara Services, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Publication

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Webinar

Faster Mapping from Source Data to Target SDTM

Certara Products - Pinnacle 21, Webinar

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

Certara Products - Simcyp, Modeling and Simulation, Modeling and Simulation - PBPK, Pharmacometrics, Blog

Transform Your PK/PD Workflow with AI and the Cloud

Certara Products - Phoenix, Webinar - Resources LP - Upcoming, Webinar

PSI 2025 Conference

Certara Products, Certara Services, Conference LP - Latest, Conference

2025 Korea CDISC Day

Conference LP - Latest, Conference

薬事・メディカルライティング向け生成AI

Webinar - Resources LP - Upcoming, Webinar

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

Certara Products - Simcyp, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, On-Demand Webinar

CERTAINTY 2025: The power of Model-Informed Drug Development

event, Late clinical - blog, Modeling and Simulation, Blog

Extrapolating AUC to Infinity

サターラの製品 - Phoenix、モデリングおよびシミュレーション - PK/PD、ブログ、ナレッジベース

Bio International Convention 2025

展示会・学会

1
2
3
…
37
›

ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software